The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Mesalamine API Market Research Report 2025
Synopsis
Mesalamine?was?approved?for?medical?use?in?the?United?States?in?1987.?Mesalamine,?also?known?as?mesalazine?or?5-aminosalicylic?acid?(5-ASA),?is?a?medication?used?to?treat?inflammatory?bowel?disease,?including?ulcerative?colitis?and?Crohn's?disease.?It?is?generally?used?for?mildly?to?moderately?severe?disease.?It?is?taken?by?mouth?or?rectally.?The?formulations?which?are?taken?by?mouth?appear?to?be?similarly?effective.
The global Mesalamine API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mesalamine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalamine API.
Report Scope
The Mesalamine API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mesalamine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalamine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
PharmaZell
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Segment by Type
Purity ≥ 97 %
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Mesalamine Tablets
Mesalamine Capsules
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mesalamine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Mesalamine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Mesalamine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Mesalamine?was?approved?for?medical?use?in?the?United?States?in?1987.?Mesalamine,?also?known?as?mesalazine?or?5-aminosalicylic?acid?(5-ASA),?is?a?medication?used?to?treat?inflammatory?bowel?disease,?including?ulcerative?colitis?and?Crohn's?disease.?It?is?generally?used?for?mildly?to?moderately?severe?disease.?It?is?taken?by?mouth?or?rectally.?The?formulations?which?are?taken?by?mouth?appear?to?be?similarly?effective.
The global Mesalamine API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mesalamine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalamine API.
Report Scope
The Mesalamine API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mesalamine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalamine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
PharmaZell
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
Segment by Type
Purity ≥ 97 %
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Mesalamine Tablets
Mesalamine Capsules
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mesalamine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Mesalamine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Mesalamine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Mesalamine API Market Overview
1.1 Product Definition
1.2 Mesalamine API Segment by Type
1.2.1 Global Mesalamine API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity ≥ 97 %
1.2.3 Purity ≥ 98 %
1.2.4 Purity ≥ 99 %
1.3 Mesalamine API Segment by Application
1.3.1 Global Mesalamine API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Mesalamine Tablets
1.3.3 Mesalamine Capsules
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Mesalamine API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Mesalamine API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Mesalamine API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Mesalamine API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Mesalamine API Production Market Share by Manufacturers (2019-2024)
2.2 Global Mesalamine API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Mesalamine API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Mesalamine API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Mesalamine API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Mesalamine API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Mesalamine API, Product Offered and Application
2.8 Global Key Manufacturers of Mesalamine API, Date of Enter into This Industry
2.9 Mesalamine API Market Competitive Situation and Trends
2.9.1 Mesalamine API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Mesalamine API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Mesalamine API Production by Region
3.1 Global Mesalamine API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Mesalamine API Production Value by Region (2019-2030)
3.2.1 Global Mesalamine API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Mesalamine API by Region (2025-2030)
3.3 Global Mesalamine API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Mesalamine API Production by Region (2019-2030)
3.4.1 Global Mesalamine API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Mesalamine API by Region (2025-2030)
3.5 Global Mesalamine API Market Price Analysis by Region (2019-2024)
3.6 Global Mesalamine API Production and Value, Year-over-Year Growth
3.6.1 North America Mesalamine API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Mesalamine API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Mesalamine API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Mesalamine API Production Value Estimates and Forecasts (2019-2030)
4 Mesalamine API Consumption by Region
4.1 Global Mesalamine API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Mesalamine API Consumption by Region (2019-2030)
4.2.1 Global Mesalamine API Consumption by Region (2019-2024)
4.2.2 Global Mesalamine API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Mesalamine API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Mesalamine API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Mesalamine API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Mesalamine API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Mesalamine API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Mesalamine API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Mesalamine API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Mesalamine API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Mesalamine API Production by Type (2019-2030)
5.1.1 Global Mesalamine API Production by Type (2019-2024)
5.1.2 Global Mesalamine API Production by Type (2025-2030)
5.1.3 Global Mesalamine API Production Market Share by Type (2019-2030)
5.2 Global Mesalamine API Production Value by Type (2019-2030)
5.2.1 Global Mesalamine API Production Value by Type (2019-2024)
5.2.2 Global Mesalamine API Production Value by Type (2025-2030)
5.2.3 Global Mesalamine API Production Value Market Share by Type (2019-2030)
5.3 Global Mesalamine API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Mesalamine API Production by Application (2019-2030)
6.1.1 Global Mesalamine API Production by Application (2019-2024)
6.1.2 Global Mesalamine API Production by Application (2025-2030)
6.1.3 Global Mesalamine API Production Market Share by Application (2019-2030)
6.2 Global Mesalamine API Production Value by Application (2019-2030)
6.2.1 Global Mesalamine API Production Value by Application (2019-2024)
6.2.2 Global Mesalamine API Production Value by Application (2025-2030)
6.2.3 Global Mesalamine API Production Value Market Share by Application (2019-2030)
6.3 Global Mesalamine API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Syntese A/S
7.1.1 Syntese A/S Mesalamine API Corporation Information
7.1.2 Syntese A/S Mesalamine API Product Portfolio
7.1.3 Syntese A/S Mesalamine API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Syntese A/S Main Business and Markets Served
7.1.5 Syntese A/S Recent Developments/Updates
7.2 Divis Laboratories
7.2.1 Divis Laboratories Mesalamine API Corporation Information
7.2.2 Divis Laboratories Mesalamine API Product Portfolio
7.2.3 Divis Laboratories Mesalamine API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Divis Laboratories Main Business and Markets Served
7.2.5 Divis Laboratories Recent Developments/Updates
7.3 Cambrex Corporation
7.3.1 Cambrex Corporation Mesalamine API Corporation Information
7.3.2 Cambrex Corporation Mesalamine API Product Portfolio
7.3.3 Cambrex Corporation Mesalamine API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Cambrex Corporation Main Business and Markets Served
7.3.5 Cambrex Corporation Recent Developments/Updates
7.4 Ipca Laboratories
7.4.1 Ipca Laboratories Mesalamine API Corporation Information
7.4.2 Ipca Laboratories Mesalamine API Product Portfolio
7.4.3 Ipca Laboratories Mesalamine API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Ipca Laboratories Main Business and Markets Served
7.4.5 Ipca Laboratories Recent Developments/Updates
7.5 PharmaZell
7.5.1 PharmaZell Mesalamine API Corporation Information
7.5.2 PharmaZell Mesalamine API Product Portfolio
7.5.3 PharmaZell Mesalamine API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 PharmaZell Main Business and Markets Served
7.5.5 PharmaZell Recent Developments/Updates
7.6 Lasa Loboratory
7.6.1 Lasa Loboratory Mesalamine API Corporation Information
7.6.2 Lasa Loboratory Mesalamine API Product Portfolio
7.6.3 Lasa Loboratory Mesalamine API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Lasa Loboratory Main Business and Markets Served
7.6.5 Lasa Loboratory Recent Developments/Updates
7.7 Erregierre SpA
7.7.1 Erregierre SpA Mesalamine API Corporation Information
7.7.2 Erregierre SpA Mesalamine API Product Portfolio
7.7.3 Erregierre SpA Mesalamine API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Erregierre SpA Main Business and Markets Served
7.7.5 Erregierre SpA Recent Developments/Updates
7.8 Corden Pharma Bergamo
7.8.1 Corden Pharma Bergamo Mesalamine API Corporation Information
7.8.2 Corden Pharma Bergamo Mesalamine API Product Portfolio
7.8.3 Corden Pharma Bergamo Mesalamine API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Corden Pharma Bergamo Main Business and Markets Served
7.7.5 Corden Pharma Bergamo Recent Developments/Updates
7.9 CTX Lifescience
7.9.1 CTX Lifescience Mesalamine API Corporation Information
7.9.2 CTX Lifescience Mesalamine API Product Portfolio
7.9.3 CTX Lifescience Mesalamine API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 CTX Lifescience Main Business and Markets Served
7.9.5 CTX Lifescience Recent Developments/Updates
7.10 Ishita Active Pharma Ingredients
7.10.1 Ishita Active Pharma Ingredients Mesalamine API Corporation Information
7.10.2 Ishita Active Pharma Ingredients Mesalamine API Product Portfolio
7.10.3 Ishita Active Pharma Ingredients Mesalamine API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Ishita Active Pharma Ingredients Main Business and Markets Served
7.10.5 Ishita Active Pharma Ingredients Recent Developments/Updates
7.11 YC Biotech (Jiangsu)
7.11.1 YC Biotech (Jiangsu) Mesalamine API Corporation Information
7.11.2 YC Biotech (Jiangsu) Mesalamine API Product Portfolio
7.11.3 YC Biotech (Jiangsu) Mesalamine API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 YC Biotech (Jiangsu) Main Business and Markets Served
7.11.5 YC Biotech (Jiangsu) Recent Developments/Updates
7.12 Xinxiang Tianfeng Fine Chemical
7.12.1 Xinxiang Tianfeng Fine Chemical Mesalamine API Corporation Information
7.12.2 Xinxiang Tianfeng Fine Chemical Mesalamine API Product Portfolio
7.12.3 Xinxiang Tianfeng Fine Chemical Mesalamine API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Xinxiang Tianfeng Fine Chemical Main Business and Markets Served
7.12.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Mesalamine API Industry Chain Analysis
8.2 Mesalamine API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Mesalamine API Production Mode & Process
8.4 Mesalamine API Sales and Marketing
8.4.1 Mesalamine API Sales Channels
8.4.2 Mesalamine API Distributors
8.5 Mesalamine API Customers
9 Mesalamine API Market Dynamics
9.1 Mesalamine API Industry Trends
9.2 Mesalamine API Market Drivers
9.3 Mesalamine API Market Challenges
9.4 Mesalamine API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
